Psoriasis Clinical Trials

Find clinical trials for psoriasis. Search for psoriasis clinical trials in different cities and states across the United States.

Filter

Filter results

Results: 88

GuselkumabElucidating Shared Mechanisms Contributing to NAFLD and PsA Disease Severity With Guselkumab Therapy

Recruiting

Sponsor:

UCLA

Location:

San Diego CA

Code:

NCT06586281

Conditions

Psoriatic Arthritis

Eligibility Criteria

Sex: All

Age: 0 - 70+

Healthy Volunteers: Not accepted

Interventions

Guselkumab

TapinarofTapinarof for the Treatment of Plaque Psoriasis in Pediatric Subjects

Recruiting

PHASE3

Sponsor:

Dermavant Sciences, Inc.

Location:

Rogers AR, Fountain Valley CA, Rancho Santa Margarita CA, Clearwater FLshow 14 more

Code:

NCT05172726

Conditions

Plaque Psoriasis

Eligibility Criteria

Sex: All

Age: 2 - 17

Healthy Volunteers: Not accepted

Interventions

tapinarof cream, 1%

SFA002Study of SFA002 in Patients with Mild to Moderate Psoriasis Plaques

Recruiting

PHASE1

Sponsor:

SFA Therapeutics

Location:

Pompano Beach FL, Fargo ND, Philadelphia PA

Code:

NCT05642182

Conditions

Psoriasis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

SFA002

Cognitive Behavioral TherapySmart Phone Delivered Cognitive Behavioral Therapy for Adults with Psoriasis and Co-Morbid Depression Symptoms

Recruiting

Sponsor:

Brigham and Women's Hospital

Location:

Boston MA

Code:

NCT06216691

Conditions

Psoriasis

Depressive Symptoms

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Coach-guided smartphone delivered CBT program.

ILUMYA & HALOGILUMYA in Combination With HALOG Ointment 0.1% for Plaque Psoriasis.

Recruiting

Sponsor:

Psoriasis Treatment Center of Central New Jersey

Location:

East Windsor NJ

Code:

NCT04347473

Conditions

Psoriasis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Ilumya Injectable Product

Tirzepatide & IxekizumabA Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA)

Recruiting

Sponsor:

Eli Lilly and Company

Location:

Avondale AZ, Chandler AZ, Flagstaff AZ, Gilbert AZshow 48 more

Code:

NCT06864026

Conditions

Psoriatic Arthritis

Overweight or Obesity

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Tirzepatide

Observational StudyA Longitudinal Observational Study of Patients Undergoing Therapy for IMISC

Recruiting

Sponsor:

Target PharmaSolutions, Inc.

Location:

Scottsdale AZ, Fort Smith AR, Little Rock AR, Fountain Valley CAshow 51 more

Code:

NCT03661866

Conditions

Atopic Dermatitis

Alopecia Areata

Hidradenitis Suppurativa

Vitiligo

Psoriasis

Eligibility Criteria

Sex: All

Age: 0 - 70+

Healthy Volunteers: Not accepted

Deucravacitinib vs. ApremilastA Real-world Observational Study to Compare Effectiveness of Deucravacitinib Vs Apremilast in Adults With Plaque Psoriasis

Recruiting

Sponsor:

Bristol-Myers Squibb

Location:

Waltham MA

Code:

NCT05744466

Conditions

Psoriasis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Deucravacitinib

Apremilast

TAK-279A Study of TAK-279 in Participants With Moderate-to-Severe Plaque Psoriasis

Recruiting

PHASE3

Sponsor:

Takeda

Location:

Birmingham AL, Hoover AL, Phoenix AZ, Tucson AZshow 85 more

Code:

NCT06550076

Conditions

Plaque Psoriasis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

TAK-279

Enstilar & EnbrelEnstilar in Combination With Enbrel or Humira for Plaque Psoriasis

Recruiting

Sponsor:

Psoriasis Treatment Center of Central New Jersey

Location:

East Windsor NJ

Code:

NCT03827876

Conditions

Psoriasis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Enstilar 0.005%-0.064% Topical Foam